SYNTHESIS
December 1998
1819
1H NMR (CDCl3): δ = 1.22/1.27 (2t, J = 7.1 Hz, together 3H,
CH2CH3), 3.07 (perturbed br signal, 3H, N-Me), 3.71 (unresolved br
signal, 2H, N-CH2), 4.97–5.10 and 5.16–5.23 (complex, 2H, Z-CH2),
6.93 (br signal) and 7.20–7.43 (complex, 9H, Ar-H).
13C NMR (CDCl3): δ = 12.95/13.41 (CH2CH3), 21.38 (Ts-Me), 27.34
(PhCH2CH2), 28.21 (Ph(CH2)2CH2), 35.17 (PhCH2), 39.63/41.69 (N-
Me), 47.57/43.67 (CH3CH2), 71.37/70.89 [Ph(CH2)3CH2], 115.42 (d,
2JC,F~17 Hz, C3,5), 125.80, 125.90, 128.28, 128.35, 129.07, 130.27
13C NMR (CDCl3): δ = 12.67/13.25 (CH2CH3), 37.60/38.38/38.07
(N-Me), 42.50/42.86/45.99 (N-CH2), 68.28/67.98 (Z-CH2), 115.28
(Ar), 141.55/142.01 (Ts-C1), 155.49 (br urea-CO), 163.86 (d, 1JC,F
=
250.9 Hz, C4),170.52 (br, 4-FC6H4CO).
2
(d, J C,F = 20.8 Hz, C3,5), 127.87, 128.28, 128.51, 128.59, 131.25,
131.54, 135.42, 135.84 (Ar), 155.47 (Z-CO), 163.50 (d, 1JC,F = 250.3
Hz, C4), 171.32/171.82 (4-FC6H4CO).
1-(Benzyloxycarbonyl)-2-ethyl-1-methyl-2-(tosylcarbamoyl)hy-
drazine (7):
Synthesized from 2 and tosyl isocyanate essentially as described for
5. The yield of crude pure (C) product was 99% in a 5 mmol run;
white, lustrous crystals with mp 117–119°C (CH2Cl2/Et2O 1:20;
–20°C; 60 mL/g).
Anal. Calcd for C18H19FN2O3 (330.4): C, 65.44; H, 5.80; N, 8.48.
Found: C, 65.4; H, 5.8; N, 8.6.
1-Ethyl-1-(4-fluorobenzoyl)-2-methyl-2-(tosylcarbamoyl)hydra-
zine (5):
1H NMR (CDCl3): δ = 1.06 (perturbed t, J = 7.3 Hz, 3H, CH2CH3),
2.40 (s, 3H, Ts-Me), 3.12 (s, 3H, N-Me), 3.39 and 3.52 (ABq, further
split by coupling to Me, J1 = 14.4 and J2 = 7.2 Hz, 2H, CH2CH3), 5.04
and 5.09 (ABq, J = 11.9 Hz, 2H, Z-CH2), 7.23–7.32 (complex, 7H,
Ph-H + Ts-H3,5), 7.86 (d, J = 8.2 Hz, 2H, Ts-H2,6), 8.68 (br s, 1H,
NH).
Recrystallized 3 (330 mg, 1.00 mmol) was dissolved in MeOH (6 mL)
and hydrogenolyzed for 2 h at atmospheric pressure over 5% Pd/C (60
mg). The catalyst was filtered off and the product was worked up es-
sentially as described for 2. The crude, chromatographically pure 1-
ethyl-1-(4-fluorobenzoyl)-2-methylhydrazine (4) was obtained as a
colorless liquid (191 mg, 97%). This product was dissolved in anhyd
CH2Cl2 (1 mL) and cooled in ice under argon, whereupon a solution
of tosyl isocyanate (193 mg, 0.98 mmol) in anhyd CH2Cl2 (1 mL) was
introduced dropwise with rapid stirring over 10 min and left for a few
hours under stirring in ice. A white precipitate was formed, from
which the solvent was stripped off. The solid residue was triturated
with cold Et2O and chilled overnight, the insoluble product was col-
lected by filtration, repeatedly rinsed with cold Et2O and dried in vac-
uo to give crude, chromatographically pure 5 (C; 382 mg, 97% from
3); microcrystalline solid; mp 217–219°C (dec) (CHCl3; –20°C; 20
mL/g).
13C NMR (CDCl3): δ = 12.77 (CH2CH3), 21.62 (Ts-Me), 37.09 (N-
Me), 42.07 (CH2CH3), 68.63 (Z-CH2), 127.99, 128.18, 128.35,
128.55, 129.46, 135.10, 135.89 (Ar), 144.49 (Ts-C1), 151.12 (urea
CO), 155.67 (Z-CO).
Anal. Calcd for C19H23N3O5S (405.48): C, 56.28; H, 5.72; N, 10.36.
Found: C, 56.2; H, 5.8; N, 10.4.
1-(Benzyloxycarbonyl)-2-ethyl-1-methyl-2-
[(trideuteromethyl)tosylcarbamoyl]hydrazine (8a):
Obtained by Mitsunobu alkylation of 7 with [2H3]MeOH as alkylating
agent. Essentially by analogy with 6, a 5 mmol run gave pure (A, B)
8a as a colorless viscous oil in 79% yield which failed to crystallize
even after prolonged storage at –20°C.
1H NMR (DMSO-d6): δ = 1.14 (perturbed t, J = 7.1 Hz, 3H, CH2CH3),
2.42/2.37 (2s, 3H, Ts-Me), 2.72, 3.10 and 3.60 (br signal, together 5H,
N-Me + N-CH2), 6.96–7.69 (br signal) and 7.43/7.36 (2d, J = 7.7/8.3
Hz) and 7.78/7.71 (2d, J = 8.2/8.3 Hz, together ~8H, Ar-H), 11.82/
11.42 (br signal, 1H, NH).
1H NMR (CDCl3): δ = 1.23/1.27 (2t, J = 7.2 Hz, 3H, CH2CH3), 2.42
(s, 3H, Ts-Me), 3.25/3.31 (2s, 3H, N-Me), 3.64–3.81 (2 perturbed m,
2H, CH2CH3), 5.16 and 5.11/5.18 (ABq/s, J = 11.9 Hz, 2H, Z-CH2),
7.29–7.36 (complex, 7H, Ph-H + Ts-H3,5), 7.75/7.81 (2d, J = 8.3 Hz,
2H, Ts-H2,6).
13C NMR (DMSO-d6): δ = 11.61/12.30 (CH2CH3), 21.03/20.87 (Ts-
Me), 36.1, 41.6, 42.2, 45.4 (br signal, partly obscured by solvent, N-
2
Me + N-CH2), 114.90 (d, JC,F = 21.2 Hz, C3,5), 125.59, 127.52,
13C NMR (CDCl3): δ = 12.45 (CH2CH3), 21.57 (Ts-Me), 33.7–34.6
(2 overlapping m, JC,D≈11 Ηz, CD3), 36.48/37.61 (N-Me), 45.73/
45.10 (CH2CH3), 68.27/68.17 (Z-CH2), 127.84, 128.24, 128.29,
128.31, 128.46, 128.56, 128.72, 128.75, 129.45, 133.44, 133.62,
135.52, 135.76 (Ar), 144.49/144.39 (Ts-C1), 155.66, 155.75, 155.79,
156.31 (CO).
128.20, 128.83, 129.32, 130.0, 131.79, 136.98, 141.42, 141.81,
1
143.74 (Ar), 151.82 (br urea-CO), 162.62 (d, JC,F = 246.3 Hz, C4),
170.73 (br, 4-FC6H4CO).
Anal. Calcd for C18H20FN3O4S (393.44): C, 54.95; H, 5.12; N, 10.68.
Found: C, 54.6; H, 5.2; N, 10.6.
1-(Benzyloxycarbonyl)-2-ethyl-2-[(isobutyl)tosylcarbamoyl]-1-
methylhydrazine (8b):
1-Ethyl-1-(4-fluorobenzoyl)-2-methyl-2-[(4-phenylbutyl)tosyl-
carbamoyl]hydrazine (6):
Synthesized from 7 and i-BuOH according to Mitsunobu. A 2.5 mmol
run afforded pure (A, B) 8b in 59% yield as a pale yellow oil.
1H NMR (CDCl3): δ = 0.84/0.91 [t/d, J = ~6/6.7 Hz, 6H, CH(CH3)2],
1.18/1.26 (2t, J = 7.2 Hz, 3H, CH2CH3), 1.83 and 1.94 (2 perturbed
m, 1H, CH), 2.40/2.38 (2s, 3H, Ts-Me), 3.20/3.29 (2s, 3H, N-Me),
3.52–3.60 and 3.68–3.82 (complex, 2H, CH2CH3), 4.04/3.96/4.07/
3.94/3.98 (5d, partly obscured, J = 6.3 Hz, 2H, i-Bu-CH2), 5.15 and
Recrystallized 5 (492 mg, 1.25 mmol) was suspended in anhyd THF
(5 mL; freshly distilled from Na/Ph2CO) and 4-phenylbutanol (235
mg, 1.56 mmol) added with gentle mixing under argon. Anhyd Ph3P
(492 mg, 1.56 mmol) was introduced in one portion and after a few
minutes the resulting turbid mixture was treated with diethyl azodi-
carboxylate (340 µL, 2.19 mmol) dropwise with rapid stirring over 15
min until a pale yellow color prevailed. The now clear mixture was
then stirred for 15 h with exclusion of moisture. The solvent was
stripped off at reduced pressure and the yellow oily residue was dis-
solved in CH2Cl2 and again taken to complete dryness. The residual
semisolid material was dissolved in CH2Cl2 and applied to a silica gel
column packed in CH2Cl2/Et2O 20:1. Slow elution gave first a yel-
lowish forerun (discarded) and then the desired compound as a pure
(C) colorless glassy oil (403 mg, 61%), which failed to crystallize
after prolonged standing at –20°C.
5.12/5.22 and 5.12 (2ABq, J = 12.1 Hz, 2H, Z-CH2), 7.21–7.40 (com-
.
plex, 7H, Ph-H + Ts-H3,5), 7.79/7.83 (2d, J = 8.2 Hz, 2H, Ts-H2,6
)
13C NMR (CDCl3): δ = 13.02/12.66 (CH2CH3), 18.84/18.97/18.82
[CH(CH3)2], 21.41/21.38 (Ts-Me), 27.92/27.85 (CHMe2), 37.89/
36.90 (N-Me), 46.17 and 46.37 (2N-CH2), 68.31/68.45 (Z-CH2),
125.76, 125.84, 128.17, 128.23, 128.43, 128.46, 128.91, 129.02,
135.74, 135.87 (Ar), 141.75/141.89/141.55/142.08 (Ts-C1), 155.30,
155.51, 155.64, 155.83 (CO).
1H NMR (CDCl3): δ = 1.22 (br signal, 3H, CH2CH3), 1.63 [br signal,
4H, PhCH2(CH2)2], 2.38 (s, 3H, Ts-Me), 2.57 (br signal, 2H, PhCH2),
3.36, 3.49 and 3.78 (br signal, together 5H, N-Me + N-CH2CH3), 4.22
[br signal, 2H, Ph(CH2)3CH2], 7.04–7.29 (complex), 7.44 and 7.80
(br signal, together 13H, Ar).
1-Ethyl-2-methyl-2-(tosylcarbamoyl)-1-[(trideuteromethyl)tosyl-
carbamoyl]hydrazine (10):
Chromatographed 8a (380 mg, 0.90 mmol) was dissolved in MeOH
(15 mL) and hydrogenolyzed for 2 h over 5% Pd/C. After filtration
and evaporation, the residual colorless oil was dissolved in CH2Cl2